(Q37970113)

English

Dabigatran etexilate for the prevention of venous thromboembolism in patients undergoing elective hip or knee surgery: a NICE single technology appraisal

scientific article published on February 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Dabigatran etexilate for the prevention of venous thromboembolism in patients undergoing elective hip or knee surgery: a NICE single technology appraisal (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

0 references

1 reference

based on heuristic

inferred from title

venous thromboembolism

1 reference

based on heuristic

inferred from title

author name string

Michael Holmes

1

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Christopher Carroll

2

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Diana Papaioannou

3

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

publication date

1 February 2012

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

PharmacoEconomics

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

137-146

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Single technology appraisal at the UK National Institute for Health and clinical excellence: a source of evidence and analysis for decision making internationally

1 reference

https://api.crossref.org/works/10.2165%2F11591590-000000000-00000

21 January 2018

Alitretinoin for severe chronic hand eczema: a NICE single technology appraisal

1 reference

https://api.crossref.org/works/10.2165%2F11591590-000000000-00000

21 January 2018

Cetuximab for recurrent and/or metastatic squamous cell carcinoma of the head and neck: a NICE single technology appraisal

1 reference

https://api.crossref.org/works/10.2165%2F11591590-000000000-00000

21 January 2018

Febuxostat for the management of hyperuricaemia in patients with gout: a NICE single technology appraisal

1 reference

https://api.crossref.org/works/10.2165%2F11591590-000000000-00000

21 January 2018

Denosumab for the prevention of osteoporotic fractures in post-menopausal women: a NICE single technology appraisal.

1 reference

https://api.crossref.org/works/10.2165%2F11591590-000000000-00000

21 January 2018

Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial.

1 reference

https://api.crossref.org/works/10.2165%2F11591590-000000000-00000

21 January 2018

Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial.

1 reference

https://api.crossref.org/works/10.2165%2F11591590-000000000-00000

21 January 2018

Interaction revisited: the difference between two estimates

1 reference

https://api.crossref.org/works/10.2165%2F11591590-000000000-00000

21 January 2018

Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies.

1 reference

https://api.crossref.org/works/10.2165%2F11591590-000000000-00000

21 January 2018

Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery: a multicenter, randomized, placebo-controlled, double-blind study

1 reference

https://api.crossref.org/works/10.2165%2F11591590-000000000-00000

21 January 2018

Dronedarone for the treatment of atrial fibrillation: a NICE single technology appraisal

1 reference

https://pubmed.ncbi.nlm.nih.gov/22185183

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Golimumab for the treatment of psoriatic arthritis: a NICE single technology appraisal

1 reference

https://pubmed.ncbi.nlm.nih.gov/22185183

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Omalizumab for the treatment of severe persistent allergic asthma in children aged 6-11 years: a NICE single technology appraisal

1 reference

https://pubmed.ncbi.nlm.nih.gov/22185183

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Erlotinib monotherapy for the maintenance treatment of non-small cell lung cancer after previous platinum-containing chemotherapy: a NICE single technology appraisal.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22185183

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bevacizumab for metastatic colorectal cancer: a NICE single technology appraisal

1 reference

https://pubmed.ncbi.nlm.nih.gov/22185183

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The authors' reply to Allen et al.: "A Comment on Boyers et al.: 'eltrombopag for the treatment of chronic immune or idiopathic thrombocytopenic purpura: a NICE single technology appraisal'".

1 reference

https://pubmed.ncbi.nlm.nih.gov/22185183

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/11591590-000000000-00000

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37970113&oldid=2201124102"